Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation

被引：8

作者：

Baker, GM

Martin, JE

Jang, R

Schroeder, TJ

Armitstead, JA

Myre, S

First, MR

机构：

[1] Univ Cincinnati, Med Ctr, Dept Pharm, Cincinnati, OH 45267 USA

[2] Univ Cincinnati, Med Ctr, Dept Internal Med, Cincinnati, OH 45267 USA

[3] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA

来源：

关键词：

D O I：

10.1016/S0041-1345(98)01349-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：4082 / 4084

页数：3

共 8 条

[1] Danovitch G, 1996, TRANSPLANTATION, V61, P722
[2] DANOVITCH GM, 1995, KIDNEY INT, V48, pS93
[3] Gonwa TA, 1996, CLIN TRANSPLANT, V10, P128
[4] GRINYO J, 1995, LANCET, V345, P1321
[5] Keown P, 1996, TRANSPLANTATION, V61, P1029
[6] KEOWN PA, 1997, AM SOC TRANSPL PHYS
[7] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
SOLLINGER, HW
[J]. TRANSPLANTATION, 1995, 60 (03) : 225 - 232
[8] Sullivan SD, 1997, J AM SOC NEPHROL, V8, P1592